Literature DB >> 24458155

Noninvasive imaging of retinal morphology and microvasculature in obese mice using optical coherence tomography and optical microangiography.

Zhongwei Zhi1, Jennifer R Chao, Tomasz Wietecha, Kelly L Hudkins, Charles E Alpers, Ruikang K Wang.   

Abstract

PURPOSE: To evaluate early diabetes-induced changes in retinal thickness and microvasculature in a type 2 diabetic mouse model by using optical coherence tomography (OCT)/optical microangiography (OMAG).
METHODS: Twenty-two-week-old obese (OB) BTBR mice (n = 10) and wild-type (WT) control mice (n = 10) were imaged. Three-dimensional (3D) data volumes were captured with spectral domain OCT using an ultrahigh-sensitive OMAG scanning protocol for 3D volumetric angiography of the retina and dense A-scan protocol for measurement of the total retinal blood flow (RBF) rate. The thicknesses of the nerve fiber layer (NFL) and that of the NFL to the inner plexiform layer (IPL) were measured and compared between OB and WT mice. The linear capillary densities within intermediate and deep capillary layers were determined by the number of capillaries crossing a 500-μm line. The RBF rate was evaluated using an en face Doppler approach. These quantitative measurements were compared between OB and WT mice.
RESULTS: The retinal thickness of the NFL to IPL was significantly reduced in OB mice (P < 0.01) compared to that in WT mice, whereas the NFL thickness between the two was unchanged. 3D depth-resolved OMAG angiography revealed the first in vivo 3D model of mouse retinal microcirculation. Although no obvious differences in capillary vessel densities of the intermediate and deep capillary layers were detected between normal and OB mice, the total RBF rate was significantly lower (P < 0.05) in OB mice than in WT mice.
CONCLUSIONS: We conclude that OB BTBR mice have significantly reduced NFL-IPL thicknesses and total RBF rates compared with those of WT mice, as imaged by OCT/OMAG. OMAG provides an unprecedented capability for high-resolution depth-resolved imaging of mouse retinal vessels and blood flow that may play a pivotal role in providing a noninvasive method for detecting early microvascular changes in patients with diabetic retinopathy.

Entities:  

Keywords:  obesity; optical coherence tomography; retinal microcirculation; retinal vasculature

Mesh:

Year:  2014        PMID: 24458155      PMCID: PMC3931296          DOI: 10.1167/iovs.13-12864

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  40 in total

1.  Noninvasive imaging of in vivo blood flow velocity using optical Doppler tomography.

Authors:  Z Chen; T E Milner; S Srinivas; X Wang; A Malekafzali; M J van Gemert; J S Nelson
Journal:  Opt Lett       Date:  1997-07-15       Impact factor: 3.776

2.  Real-time phase-resolved functional optical coherence tomography by use of optical Hilbert transformation.

Authors:  Yonghua Zhao; Zhongping Chen; Zhihua Ding; Hongwu Ren; J Stuart Nelson
Journal:  Opt Lett       Date:  2002-01-15       Impact factor: 3.776

3.  Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus.

Authors:  Susanne M Clee; Brian S Yandell; Kathryn M Schueler; Mary E Rabaglia; Oliver C Richards; Summer M Raines; Edward A Kabara; Daniel M Klass; Eric T-K Mui; Donald S Stapleton; Mark P Gray-Keller; Matthew B Young; Jonathan P Stoehr; Hong Lan; Igor Boronenkov; Philipp W Raess; Matthew T Flowers; Alan D Attie
Journal:  Nat Genet       Date:  2006-05-07       Impact factor: 38.330

4.  Genetic and genomic studies of the BTBR ob/ob mouse model of type 2 diabetes.

Authors:  Susanne M Clee; Samuel T Nadler; Alan D Attie
Journal:  Am J Ther       Date:  2005 Nov-Dec       Impact factor: 2.688

5.  Ultrahigh sensitive optical microangiography for in vivo imaging of microcirculations within human skin tissue beds.

Authors:  Lin An; Jia Qin; Ruikang K Wang
Journal:  Opt Express       Date:  2010-04-12       Impact factor: 3.894

6.  Retinal circulatory abnormalities in type 1 diabetes.

Authors:  G T Feke; S M Buzney; H Ogasawara; N Fujio; D G Goger; N P Spack; K H Gabbay
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-06       Impact factor: 4.799

7.  Structural and hemodynamic analysis of the mouse retinal microcirculation.

Authors:  Michel Paques; Ramin Tadayoni; Richard Sercombe; Pierre Laurent; Olivier Genevois; Alain Gaudric; Eric Vicaut
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

Review 8.  Retinal blood flow in diabetes.

Authors:  Allen C Clermont; Sven-Erik Bursell
Journal:  Microcirculation       Date:  2007-01       Impact factor: 2.628

9.  Measurement of retinal blood flow rate in diabetic rats: disparity between techniques due to redistribution of flow.

Authors:  Wendy Leskova; Megan N Watts; Patsy R Carter; Randa S Eshaq; Norman R Harris
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-26       Impact factor: 4.799

Review 10.  Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals.

Authors:  Remya Robinson; Veluchamy A Barathi; Shyam S Chaurasia; Tien Y Wong; Timothy S Kern
Journal:  Dis Model Mech       Date:  2012-07       Impact factor: 5.758

View more
  24 in total

1.  Ratiometric analysis of optical coherence tomography-measured in vivo retinal layer thicknesses for the detection of early diabetic retinopathy.

Authors:  Basanta Bhaduri; Ryan L Shelton; Ryan M Nolan; Lucas Hendren; Alexandra Almasov; Leanne T Labriola; Stephen A Boppart
Journal:  J Biophotonics       Date:  2017-06-21       Impact factor: 3.207

2.  4D optical coherence tomography-based micro-angiography achieved by 1.6-MHz FDML swept source.

Authors:  Zhongwei Zhi; Wan Qin; Jingang Wang; Wei Wei; Ruikang K Wang
Journal:  Opt Lett       Date:  2015-04-15       Impact factor: 3.776

3.  Catalase therapy corrects oxidative stress-induced pathophysiology in incipient diabetic retinopathy.

Authors:  Courtney R Giordano; Robin Roberts; Kendra A Krentz; David Bissig; Deepa Talreja; Ashok Kumar; Stanley R Terlecky; Bruce A Berkowitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

4.  Volumetric cutaneous microangiography of human skin in vivo by VCSEL swept-source optical coherence tomography.

Authors:  Woo June Choi; Ruikang K Wang
Journal:  Quantum Elec (Woodbury)       Date:  2014       Impact factor: 1.022

5.  User-guided segmentation for volumetric retinal optical coherence tomography images.

Authors:  Xin Yin; Jennifer R Chao; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2014-08       Impact factor: 3.170

6.  Optical coherence tomography microangiography for monitoring the response of vascular perfusion to external pressure on human skin tissue.

Authors:  Woo June Choi; Hequn Wang; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2014-05       Impact factor: 3.170

7.  Volumetric fluorescence retinal imaging in vivo over a 30-degree field of view by oblique scanning laser ophthalmoscopy (oSLO).

Authors:  Lei Zhang; Weiye Song; Ji Yi; Di Shao; Sui Zhang; Manishi Desai; Steven Ness; Sayon Roy
Journal:  Biomed Opt Express       Date:  2017-12-04       Impact factor: 3.732

8.  Volumetric fluorescein angiography (vFA) by oblique scanning laser ophthalmoscopy in mouse retina at 200 B-scans per second.

Authors:  Weiye Song; Libo Zhou; Ji Yi
Journal:  Biomed Opt Express       Date:  2019-08-30       Impact factor: 3.732

9.  Retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in children with obesity.

Authors:  Selim Demir; Samet Özer; Sait Alim; Alper Güneş; Hüseyin Ortak; Resul Yılmaz
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

10.  Polarization properties of single layers in the posterior eyes of mice and rats investigated using high resolution polarization sensitive optical coherence tomography.

Authors:  Stanislava Fialová; Marco Augustin; Martin Glösmann; Tanja Himmel; Sabine Rauscher; Marion Gröger; Michael Pircher; Christoph K Hitzenberger; Bernhard Baumann
Journal:  Biomed Opt Express       Date:  2016-03-24       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.